Efficacy and Safety of Obinutuzumab in Adolescents with Active Lupus Nephritis: Primary Results from POSTERITY, a Phase II Global Trial (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #SA-OR073; Pres time: Oct 24, 2026; 04:30 PM - 04:42 PM; Location: Four Seasons Ballroom 2; No abstract available
Clinical • Late-breaking abstract • P2 data • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology
|
|
Marina Vivarelli; Deborah Levy; Gabriel Vega Cornejo; Maria T. Terreri; Aleksandra Zurowska; Adolfina E. Zuta; Joan Calzada-Hernández; Julien Hogan; Sandra Enciso-Peláez; Agustin Remesal; Louise Oni; Peiqing Yu; Felix Erblang; Olga Mitrofanova; William F. Pendergraft; Patricia B. Lehane
|